다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Korean journal of pediatrics, v.54 no.5, 2011년, pp.192 - 196
Jung, Jo-Won (Division of Pediatric Cardiology, Department of Pediatrics, Ajou University School of Medicine)
AI-Helper
Respiratory syncytial virus (RSV) is a main cause of hospitalization for bronchiolitis and pneumonia in infants worldwide. Children with hemodynamically significant congenital heart disease (HS-CHD), as well as premature infants are at high risk for severe RSV diseases. Mortality rates for CHD patie...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
1 Howard TS Hoffman LH Stang PE Simoes EA Respiratory syncytial virus pneumonia in the hospital setting: length of stay, charges, and mortality J Pediatr 2000 137 227 232 10931416
2 Nair H Nokes DJ Gessner BD Dherani M Madhi SA Singleton RJ Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis Lancet 2010 375 1545 1555 20399493
3 Hall CB Weinberg GA Iwane MK Blumkin AK Edwards KM Staat MA The burden of respiratory syncytial virus infection in young children N Engl J Med 2009 360 588 598 19196675
4 MacDonald NE Hall CB Suffin SC Alexson C Harris PJ Manning JA Respiratory syncytial viral infection in infants with congenital heart disease N Engl J Med 1982 307 397 400 7088112
5 Wright M Piedimonte G Respiratory syncytial virus prevention and therapy: Past, present, and future Pediatr Pulmonol 2011 46 324 347 21438168
6 Thompson WW Shay DK Weintraub E Brammer L Cox N Anderson LJ Mortality associated with influenza and respiratory syncytial virus in the United States JAMA 2003 289 179 186 12517228
7 The Impact-RSV Study Group Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants Pediatrics 1998 102 531 537
8 Feltes TF Cabalka AK Meissner HC Piazza FM Carlin DA Top FH Jr Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease J Pediatr 2003 143 532 540 14571236
9 Cooper DS Jacobs JP Chai PJ Jaggers J Barach P Beekman RH Pulmonary complications associated with the treatment of patients with congenital cardiac disease: consensus definitions from the Multi-Societal Database Committee for Pediatric and Congenital Heart Disease Cardiol Young 2008 18 Suppl 2 215 221 19063794
10 Feltes TF Groothuis JR Acute and long-term effects of infection by the respiratory syncytial virus in children with congenital cardiac malformations Cardiol Young 2005 15 266 273 15865828
11 Cabalka AK Physiologic risk factors for respiratory viral infections and immunoprophylaxis for respiratory syncytial virus in young children with congenital heart disease Pediatr Infect Dis J 2004 23 1 Suppl S41 S45 14730269
12 Altman CA Englund JA Demmler G Drescher KL Alexander MA Watrin C Respiratory syncytial virus in patients with congenital heart disease: a contemporary look at epidemiology and success of preoperative screening Pediatr Cardiol 2000 21 433 438 10982701
13 Navas L Wang E De Carvalho V Robinson J Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada J Pediatr 1992 121 348 354 1517907
14 Moler FW Khan AS Meliones JN Custer JR Palmisano J Shope TC Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: a recent experience Crit Care Med 1992 20 1406 1413 1395661
15 Khongphatthanayothin A Wong PC Samara Y Newth CJ Wells WJ Starnes VA Impact of respiratory syncytial virus infection on surgery for congenital heart disease: postoperative course and outcome Crit Care Med 1999 27 1974 1981 10507627
16 Boyce TG Mellen BG Mitchel EF Jr Wright PF Griffin MR Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid J Pediatr 2000 137 865 870 11113845
17 Groothuis JR Simoes EA Levin MJ Hall CB Long CE Rodriguez WJ Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children: The Respiratory Syncytial Virus Immune Globulin Study Group N Engl J Med 1993 329 1524 1530 8413475
18 Simoes EA Sondheimer HM Top FH Jr Meissner HC Welliver RC Kramer AA Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease J Pediatr 1998 133 492 499 9787686
19 American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections Pediatrics 2003 112 6 Pt 1 1442 1446 14654627
20 Zachariah P Ruttenber M Simões EA Hospitalizations due to respiratory syncytial virus in children with congenital malformations Pediatr Infect Dis J 2011 30 442 445 21127456
21 Zachariah P Simões EA Respiratory syncytial virus infection and congenital heart disease South Afr J Epidemiol Infect 2008 23 17 19
22 Saji T Nakazawa M Harada K Nationwide survey of palivizumab for respiratory syncytial virus prevention in Japanese children with congenital heart disease Pediatr Infect Dis J 2008 27 1108 1109 18978515
23 Rackham OJ Thorburn K Kerr SJ The potential impact of prophylaxis against bronchiolitis due to the respiratory syncytial virus in children with congenital cardiac malformations Cardiol Young 2005 15 251 255 15865826
24 Feltes TF Sondheimer HM Palivizumab and the prevention of respiratory syncytial virus illness in pediatric patients with congenital heart disease Expert Opin Biol Ther 2007 7 1471 1480 17727335
25 Chang RK Chen AY Impact of palivizumab on RSV hospitalizations for children with hemodynamically significant congenital heart disease Pediatr Cardiol 2010 31 90 95 19915892
26 Duppenthaler A Ammann RA Gorgievski-Hrisoho M Pfammatter JP Aebi C Low incidence of respiratory syncytial virus hospitalisations in haemodynamically significant congenital heart disease Arch Dis Child 2004 89 961 965 15383442
27 Shim WS Lee JY Song JY Lim SJ Kim SH Jang SI Respiratory syncytial virus infection cases in congenital heart disease patients Korean J Pediatr 2010 53 380 391
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.